120 related articles for article (PubMed ID: 4831715)
21. Plethysmographic recordings of skin pulses. VI. Further measurements of the vasoconstriction produced by corticosteroids.
Thune P
Acta Derm Venereol; 1972; 52(4):303-7. PubMed ID: 4115885
[No Abstract] [Full Text] [Related]
22. Influence of formulation factors on the availability of drugs from topical preparations.
Asche H; Botta L; Rettig H; Weirich EG
Pharm Acta Helv; 1985; 60(8):232-7. PubMed ID: 4070318
[No Abstract] [Full Text] [Related]
23. Evaluation of the efficacy of topical corticosteroids.
Zaynoun ST; Kurban AK
Br J Dermatol; 1974 Jan; 90(1):85-90. PubMed ID: 4811838
[No Abstract] [Full Text] [Related]
24. Vasoconstrictor and systemic activities of topical steroids.
Child KJ; English AF; Gilbert HG; Hewitt A; Woollett EA
Arch Dermatol; 1968 Apr; 97(4):407-10. PubMed ID: 4966856
[No Abstract] [Full Text] [Related]
25. Topical Corticosteroids International Symposium, Venice, May 1972. Introductory remarks.
Craps L
Acta Derm Venereol Suppl (Stockh); 1973; 53():9-11. PubMed ID: 4585162
[No Abstract] [Full Text] [Related]
26. Various vagaries of vasoconstriction.
Burdick KH
Arch Dermatol; 1974 Aug; 110(2):238-42. PubMed ID: 4855376
[No Abstract] [Full Text] [Related]
27. Steroid-induced rosacea.
Litt JZ
Am Fam Physician; 1993 Jul; 48(1):67-71. PubMed ID: 8322645
[TBL] [Abstract][Full Text] [Related]
28. Vasoconstrictor activities of some novel synthetic steroids in alcoholic solution.
Barry BW; Brace AR
J Invest Dermatol; 1975 Jun; 64(6):418-22. PubMed ID: 1141715
[TBL] [Abstract][Full Text] [Related]
29. [Penetration of topical steroids through heman skin: dependence upon ointment bases].
Hoffmann WD; Zesch A; Schaefer H
Arch Dermatol Forsch; 1974; 250(4):295-308. PubMed ID: 4447374
[No Abstract] [Full Text] [Related]
30. Experimental studies on the interactions between corticosteroids and bendazac after topical application to the skin.
Baldini A; Catanese B; De Feo G; Lisciani R
Boll Chim Farm; 1975 Jul; 114(7):401-7. PubMed ID: 1164448
[No Abstract] [Full Text] [Related]
31. [Comparison of the effectiveness of locally administered corticosteroids].
Semrádová V; Horácek J
Cesk Dermatol; 1974 Jul; 49(4):222-6. PubMed ID: 4844681
[No Abstract] [Full Text] [Related]
32. Vasoconstrictor activity and percutaneous absorption of glucocorticosteroids. A direct comparison.
Stoughton RB
Arch Dermatol; 1969 Jun; 99(6):753-6. PubMed ID: 5814595
[No Abstract] [Full Text] [Related]
33. Activity of topically applied methylprednisolone aceponate in relation to other topical glucocorticosteroids in healthy volunteers.
Kecskés A; Jahn P; Wendt H; Kleine-Kuhlmann R; Lange L
Arzneimittelforschung; 1993 Feb; 43(2):144-7. PubMed ID: 8457237
[TBL] [Abstract][Full Text] [Related]
34. Pharmacodynamics and dermatopharmacokinetics of betamethasone 17-valerate: assessment of topical bioavailability.
Wiedersberg S; Naik A; Leopold CS; Guy RH
Br J Dermatol; 2009 Mar; 160(3):676-86. PubMed ID: 18782322
[TBL] [Abstract][Full Text] [Related]
35. New approaches to assess topical corticosteroid bioequivalence: pharmacokinetic evaluation.
Pershing LK
Int J Dermatol; 1992 Oct; 31 Suppl 1():14-20. PubMed ID: 1428461
[TBL] [Abstract][Full Text] [Related]
36. [Animal experiment studies on the local activity of 9-alpha-fluoro-16-alpha-methyl-17-desoxy-prednisolone].
Schröder HG; Babej M; Vogel HG
Arzneimittelforschung; 1974 Jan; 24(1):3-5. PubMed ID: 4406107
[No Abstract] [Full Text] [Related]
37. Differential effects of betamethasone and dexamethasone fetal administration of parturition in sheep.
Derks JB; Giussani DA; Van Dam LM; Jenkins SL; Winter JA; Zhao XF; Hammond GL; Nathanielsz PW
J Soc Gynecol Investig; 1996; 3(6):336-41. PubMed ID: 8923418
[TBL] [Abstract][Full Text] [Related]
38. [The effect of urea in a topical corticoid preparation on vasoconstriction].
Früh H
Z Hautkr; 1983 Aug; 58(16):1203-5. PubMed ID: 6624181
[TBL] [Abstract][Full Text] [Related]
39. [Wound healing process during application of anabolic and catabolic steroids in the rabbit ear model according to Heite].
Heite HJ; Irro H
Arzneimittelforschung; 1973 Sep; 23(9):1341-6. PubMed ID: 4801234
[No Abstract] [Full Text] [Related]
40. [The influence of vehicule composition and corticosteroids sensitivity on the vasoconstrictor activity of a new topical corticosteroid, difluprednate (author's transl)].
Girard J; Sagon J; Barbier A; Tardieu JC; Lafille C
J Pharm Belg; 1978; 33(6):341-50. PubMed ID: 748519
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
